Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national blog main
national top stories
new york blog main
3
×
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
abbvie
activism
acute hepatic porphyria
aimmune therapeutics
allergan
allergy
alnylam pharmaceuticals
amgen
anaphylaxis
andrew oxtoby
What
treat
3
×
approval
approved
drug
fda
therapy
adults
advanced
agency
aimmune
allergan
allergy
alnylam’s
awarded
bff
bio
class
conference
deals
developed
devoted
disease
easl
form
friday
gene
immunotherapy
kicked
late
liver
major
medicines
migraine
monday
new
nod
oral
peanut
pill
race
Language
unset
Current search:
biotech
×
treat
×
" new york blog main "
×
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More